Inflammation 2010


Programme


This is the full list of presentations and speakers at the event. Some of the presentations are available to download below.

Epigenetic modulation for the future treatment of inflammatory disease 
Prof Peter Barnes, Head of Respiratory Medicine, National Heart and Lung Institute (Imperial College London)

Identification of potent and selective molecule inhibitors of the BET family bromodomains demonstrate the tractability of a new class of epigenetic targets for drug discovery
Dr Chun-wa Chung, Section Leader of Biophysical and Structural Analysis Group (GlaxoSmithKline R&D)

Agonism at prostacyclin receptors in the treatment of PAH
Dr Keith J Morrison, Senior Laboratory Head, Cardiovascular Pharmacology (Actelion) 

Identification of ALK5 inhibitors for the treatment of PAH 
Dr Duncan Shaw, Investigator (Novartis Institutes for Biomedical Research)

The discovery of novel TLR7 agonists 
Tom McInally, Team Leader (AstraZeneca) 

The discovery of CDP323, a novel and potent Inhibitor of the integrins α4β1 (VLA-4) and α4β7
Dr Julien Brown, Principal Scientist (UCB Celltech)

JAK inhibitors as novel anti-inflammatory agents
Dr Iain Kilty, Director, Allergy and Respiratory Research Unit (Pfizer Global Research and Development)

Generation and development of a series of MAPKAPK5 inhibitors for the treatment of rheumatoid arthritis
Dr Martin J I Andrews, Group Leader (Galapagos NV)


Downloadable Files


PDF files require Link icon Adobe Acrobat Reader